IRD SCHEDULE 13G/A: SEC filing

Filed with the SEC on · accession 0001193125-26-463810

IRD filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +1.5% by the first close after the filing.

Summary of the filing

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund filed an amended Schedule 13G reporting beneficial ownership of 9.99% of Opus Genetics common stock, including shares underlying pre-funded warrants subject to a 9.99% beneficial ownership limitation.

Key details

Shares of common stock beneficially owned$10.1M
Shares of common stock directly held by Master Fund$5.8M
Shares underlying pre-funded warrants$17.8M
Shares underlying pre-funded warrants currently exercisable subject to beneficial ownership limitation$4.3M
Reporting person / investment managerPerceptive Advisors LLC
Reporting person / direct holder of securitiesPerceptive Life Sciences Master Fund, Ltd.
IssuerOpus Genetics, Inc.
Managing member of perceptive advisors llcJoseph Edelman

How IRD stock reacted

Close before

$3.98

Nov 13, 2026

First close after

+1.51%

$4.04

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for IRD, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for IRD?

Click here

Frequently asked questions

What did IRD file with the SEC on Nov 16, 2026?

IRD filed a SCHEDULE 13G/A (SEC filing). Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund filed an amended Schedule 13G reporting beneficial ownership of 9.99% of Opus Genetics common stock, including shares underlying pre-funded warrants subject to a 9.99% beneficial ownership limitation.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did IRD stock react to this filing?

IRD closed at $3.98 before the filing and $4.04 on Nov 16, 2026 (+1.51%).

Other IRD SEC filings

Get alerts when IRD files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days